A 52-year-old woman with a history of metastatic breast cancer (on chemotherapy) presents with acute onset dyspnea, syncope, and chest discomfort. On examination, blood pressure is 88/54 mmHg, heart rate 132/min, respiratory rate 28/min, and JVP is elevated. Arterial blood gas shows pH 7.32, PaCO₂ 28 mmHg, PaO₂ 62 mmHg on supplemental oxygen. ECG demonstrates sinus tachycardia with right axis deviation and S₁Q₃T₃ pattern. Troponin is mildly elevated. What is the most appropriate immediate management?

Explanation

## Clinical Presentation: Massive PE with Hemodynamic Instability **Key Point:** This patient has **hemodynamically unstable PE** (massive PE) characterized by: - Syncope and hypotension (BP 88/54 mmHg) - Severe hypoxemia (PaO₂ 62 mmHg despite supplemental oxygen) - Elevated JVP (right heart strain) - ECG findings: S₁Q₃T₃ pattern (classic for acute RV strain) - Mild troponin elevation (RV infarction) - Risk factor: malignancy (hypercoagulable state) ## Risk Stratification & Management Algorithm ```mermaid flowchart TD A[PE confirmed or highly suspected]:::outcome --> B{Hemodynamically stable?}:::decision B -->|Yes| C[Anticoagulation alone]:::action B -->|No: Shock/SBP <90| D{Contraindications to thrombolysis?}:::decision D -->|No| E[Thrombolysis]:::action D -->|Yes| F[Mechanical thrombectomy]:::action E --> G[Anticoagulation after lysis]:::action F --> G C --> H[Monitor & escalate if deterioration]:::action ``` **High-Yield:** In **hemodynamically unstable PE (massive PE)**, thrombolysis is the standard of care and should NOT be delayed for CTPA confirmation if clinical suspicion is very high [cite:Harrison 21e Ch 297]. ## Thrombolysis vs. Anticoagulation in Massive PE | Feature | Anticoagulation Alone | Thrombolysis | |---------|----------------------|---------------| | **Indication** | Hemodynamically stable PE | Hemodynamically unstable PE (shock, SBP <90) | | **Mortality benefit** | No mortality benefit in massive PE | Reduces mortality in massive PE | | **Time to effect** | Gradual (days) | Rapid (minutes to hours) | | **Bleeding risk** | Lower | Higher (but justified in massive PE) | | **Contraindications** | Few (relative) | Absolute: recent surgery, intracranial pathology, active bleeding | **Clinical Pearl:** The **S₁Q₃T₃ pattern** (S wave in lead I, Q wave in lead III, T wave inversion in lead III) is a classic but insensitive ECG finding in acute PE; when present with hemodynamic instability, it strongly suggests **acute RV strain** and mandates aggressive therapy. ## Why Thrombolysis (Alteplase) Is Correct 1. **Hemodynamic instability:** Syncope + hypotension + elevated JVP = massive PE 2. **No absolute contraindications evident:** No mention of recent surgery, intracranial disease, or active bleeding 3. **Rapid clot dissolution:** Alteplase (tissue plasminogen activator) rapidly restores pulmonary perfusion and RV function 4. **Mortality reduction:** Thrombolysis reduces mortality in hemodynamically unstable PE by 50–60% [cite:Harrison 21e Ch 297] 5. **Standard of care:** Guidelines recommend thrombolysis as first-line for massive PE ## Why Not the Other Options? - **Immediate CTPA + heparin:** While CTPA confirms diagnosis, **delaying thrombolysis to obtain CTPA in a hemodynamically unstable patient is dangerous**. Clinical diagnosis is sufficient; thrombolysis should begin immediately. - **Mechanical thrombectomy:** Reserved for patients with absolute contraindications to thrombolysis (e.g., recent intracranial surgery, active bleeding) or thrombolysis failure. This patient has no documented contraindications. - **Supportive care alone:** Oxygen and observation are insufficient for massive PE; the patient is in cardiogenic shock and will deteriorate without definitive therapy.